Undisclosed RNAi Program(s)
Rare Genetic Neurological/Neuromuscular Disease
Pre-clinicalActive
Key Facts
Indication
Rare Genetic Neurological/Neuromuscular Disease
Phase
Pre-clinical
Status
Active
Company
About Armatus Bio
Armatus Bio is a private, pre-clinical stage biotech pioneering vectorized RNAi therapeutics for rare neurological disorders. The company's core strategy involves engineering novel viral capsids to enable precise, durable delivery of RNAi payloads to target tissues, particularly the central and peripheral nervous systems. Founded in 2021 and based in Cambridge, MA, it is a pre-revenue company building a pipeline for high-unmet-need genetic diseases. Its work represents a convergence of gene therapy and RNAi technologies aimed at overcoming historical delivery challenges.
View full company profile